Arkolith/Insider Trading/INBX/Form 4

Vuori Kristiina MD

DirectorInhibrx Biosciences, Inc. (INBX) · full profile →Form 4 · filed Sep 12, 2024
Net Buying
Open-Market Buys
$100K
Open-Market Sells
$0
Net Open-Market Flow
$100K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 11, 2024Buy(P)6K$15.07$97K14K
Sep 10, 2024Buy(P)179$15.00$3K7K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002007919-24-000047) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML